About EndoGastric Solutions
EndoGastric Solutions (EGS) is a medical device company focused on developing and commercializing innovative, evidence-based, non-invasive surgical technology for the treatment of gastroesophageal reflux disease (GERD).
Our mission is to combine the most advanced concepts in gastroenterology and surgery to develop products and procedures that address unmet needs in gastrointestinal diseases.
EGS’ proprietary technology platform, the EsophyX® fastener delivery system, is designed to reconstruct the gastroesophageal valve (GEV) and restore its function as a barrier, preventing stomach acids refluxing back into the esophagus. EGS is committed to further developing and commercializing innovative, evidence-based, incisionless surgical technology.
The original EsophyX® device and SerosaFuse® fasteners were CE marked in 2006 and cleared by the FDA in 2007. The technology has continued to evolve with the launch of the company’s third, third generation device, the EsophyX Z+ device in 2017. The device is commercially available in the United States and numerous other OUS countries, and used by both gastroenterologists and surgeons to treat GERD.
The EsophyX device is used to perform the company’s TIF® procedure (Transoral Incisionless Fundoplication)—a surgical solution performed without the need for external incisions through the skin that enables physicians to reconstruct the gastroesophageal valve from within the stomach and correct the root cause of GERD.